Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Hypertension Pulmonary Secondary Heart Failure
Clinical Trial
NCT03624010Last updated: 12/4/2025
TENX
TENAX THERAPEUTICS, INC.
